Further CelGro® nerve clinical trial data from all patients at 12 months post treatment on track for release in Q2 2021.
Paul A back May 18th next week and May halfway through, we know these results will be positive, are due any day now and that OCC is flying under the market radar.
I just can't wait for the trading halt announcement.......
One would think OCC will have a great churn in volume and price spike into the mid 60 cents range but the big deal that will fix the share register and tighten up and dilute retail holders is the J & J results in August and a potential dental distribution deal prior to that.
Should be an interesting couple of months.
Further CelGro® nerve clinical trial data from all patients at 12 months
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.0¢ |
Change
0.120(21.8%) |
Mkt cap ! $134.1M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 68.0¢ | 56.5¢ | $1.895M | 3.009M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 37691 | 66.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 67.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.57pm 10/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |